Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Cardizem

dilTIAZem
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
CardiZEM SR CAPSULE, EXTENDED RELEASE, ORAL 60 mg/12 hours, 90 mg/12 hours, 120 mg/12 hours    
CardiZEM CD, Cartia XT CAPSULE, EXTENDED RELEASE, ORAL 120 mg/24 hours, 180 mg/24 hours, 240 mg/24 hours      
Tiazac, Taztia XT, Dilacor CAPSULE, EXTENDED RELEASE, ORAL 120 mg,180 mg, 240 mg, 300 mg, 360 mg    
CardiZEM CD, Cartia XT CAPSULE, EXTENDED RELEASE, ORAL 300 mg/24 hours, 360 mg/24 hours      
Tiazac, Taztia XT CAPSULE, EXTENDED RELEASE, ORAL 420 mg/24 hours      
CardiZEM POWDER FOR INJECTION, INTRAVENOUS 100 mg      
CardiZEM SOLUTION, INTRAVENOUS 5 mg/mL      
CardiZEM LA, Matzim LA TABLET, EXTENDED RELEASE, ORAL 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, 420 mg    
CardiZEM TABLET, ORAL 30 mg, 60 mg, 90 mg      


Comments:

dilTIAZem 12 hour products are non-formulary and are to be interchanged to the once daily 24 hour capsule at the same daily dose. 

No distinction is made between 24 hour extended release products, the lowest cost option will be stocked.

Reviewed: July 27, 2005 (CardiZEM LA)


Last updated: Feb. 22, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.